RETT Corporation

RETT (Receptor, Enzyme, Transporter Technology) Corporation is a privately held company possessing proprietary technologies that enable superior pharmaceutical discovery and development, in-vitro ADMET analysis, and related diagnostic opportunities.

Specifically, our technologies enable the investigation of complex membrane bound proteins and features, such as ion channels and G-protein coupled receptors. These membrane-bound proteins and channels make up around 50% of the targets against which drugs are currently being developed.

Further Information: http://www.rettcorp.com